End-of-day quote
Shanghai S.E.
06:00:00 2024-07-15 pm EDT
|
5-day change
|
1st Jan Change
|
29.37
CNY
|
+0.24%
|
|
+0.51%
|
-11.80%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
10,208
|
18,166
|
30,049
|
18,378
|
19,974
|
17,588
|
-
|
-
|
Enterprise Value (EV)
1 |
10,208
|
18,166
|
30,049
|
18,378
|
19,974
|
17,588
|
17,588
|
17,588
|
P/E ratio
|
31.1
x
|
44.3
x
|
91.5
x
|
62.9
x
|
49
x
|
33.7
x
|
27.3
x
|
23.3
x
|
Yield
|
-
|
-
|
0.18%
|
0.26%
|
1.77%
|
0.48%
|
0.54%
|
0.68%
|
Capitalization / Revenue
|
4.62
x
|
8.88
x
|
13
x
|
7.35
x
|
6.79
x
|
4.82
x
|
4.09
x
|
3.46
x
|
EV / Revenue
|
4.62
x
|
8.88
x
|
13
x
|
7.35
x
|
6.79
x
|
4.82
x
|
4.09
x
|
3.46
x
|
EV / EBITDA
|
23.7
x
|
34.2
x
|
-
|
-
|
35.2
x
|
26.7
x
|
22.3
x
|
18.5
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
4.54
x
|
7.42
x
|
11
x
|
6.15
x
|
5.96
x
|
4.87
x
|
4.36
x
|
3.87
x
|
Nbr of stocks (in thousands)
|
585,988
|
585,988
|
597,152
|
596,121
|
599,831
|
598,839
|
-
|
-
|
Reference price
2 |
17.42
|
31.00
|
50.32
|
30.83
|
33.30
|
29.37
|
29.37
|
29.37
|
Announcement Date
|
4/28/20
|
4/15/21
|
4/14/22
|
4/11/23
|
4/24/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,208
|
2,046
|
2,308
|
2,500
|
2,944
|
3,651
|
4,299
|
5,085
|
EBITDA
1 |
431.5
|
530.7
|
-
|
-
|
566.9
|
659
|
787.5
|
948.5
|
EBIT
1 |
364.2
|
468.9
|
333.7
|
302.1
|
427.4
|
502
|
642.3
|
794.3
|
Operating Margin
|
16.49%
|
22.92%
|
14.46%
|
12.08%
|
14.52%
|
13.75%
|
14.94%
|
15.62%
|
Earnings before Tax (EBT)
1 |
378.1
|
467.1
|
334.8
|
305.7
|
427
|
527
|
646
|
797.7
|
Net income
1 |
330.6
|
410.5
|
326.6
|
298.2
|
406.6
|
521.4
|
644.9
|
756.7
|
Net margin
|
14.97%
|
20.06%
|
14.15%
|
11.93%
|
13.81%
|
14.28%
|
15%
|
14.88%
|
EPS
2 |
0.5600
|
0.7000
|
0.5500
|
0.4900
|
0.6800
|
0.8725
|
1.075
|
1.260
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
0.0900
|
0.0800
|
0.5900
|
0.1400
|
0.1600
|
0.2000
|
Announcement Date
|
4/28/20
|
4/15/21
|
4/14/22
|
4/11/23
|
4/24/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
15.1%
|
17.5%
|
12.8%
|
10.3%
|
12.6%
|
14%
|
15.4%
|
16.7%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
6.18%
|
4.64%
|
5.73%
|
6.48%
|
7.61%
|
8.8%
|
Assets
1 |
-
|
-
|
5,283
|
6,421
|
7,098
|
8,052
|
8,474
|
8,603
|
Book Value Per Share
2 |
3.840
|
4.180
|
4.570
|
5.010
|
5.590
|
6.030
|
6.740
|
7.580
|
Cash Flow per Share
2 |
0.7100
|
0.3500
|
-
|
0.1700
|
0.3100
|
0.8800
|
0.8800
|
1.000
|
Capex
1 |
71
|
80.4
|
-
|
344
|
141
|
123
|
154
|
161
|
Capex / Sales
|
3.21%
|
3.93%
|
-
|
13.77%
|
4.79%
|
3.37%
|
3.57%
|
3.17%
|
Announcement Date
|
4/28/20
|
4/15/21
|
4/14/22
|
4/11/23
|
4/24/24
|
-
|
-
|
-
|
Last Close Price
29.37
CNY Average target price
35
CNY Spread / Average Target +19.17% Consensus |
1st Jan change
|
Capi.
|
---|
| -11.80% | 2.42B | | +23.61% | 70.02B | | -4.13% | 47.08B | | +21.30% | 44.25B | | +35.36% | 29.07B | | +4.99% | 18.91B | | +12.71% | 17.15B | | -5.06% | 16.11B | | -28.83% | 14.28B | | -29.23% | 12.17B |
Other Specialty Chemicals
|